Properties of Cell Sources in Tissue-Engineered Three-dimensional Oral Mucosa Model: A Review
Journal:
Current Stem Cell Research & Therapy
Volume:
12
Page:
52-60
Author(s):
Nurul Hafizah Mohd. Nor, Zurairah Berahim, Azlina Ahmad and Thirumulu Ponnuraj Kannan
Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Journal:
Current Stem Cell Research & Therapy
Volume:
12
Page:
37-44
Author(s):
Rohit P. Nagare, Smarakan Sneha, Syama Krishna Priya and Trivadi S. Ganesan
Overview of Systems Biology and Omics Technologies
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
4221-4230
Author(s):
Bensu Karahalil
New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
4176-4220
Author(s):
Marianna Zajac, Izabela Muszalska and Anna Jelinska
UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target
Journal:
Current Cancer Drug Targets
Volume:
17
Page:
53-61
Author(s):
Samantha Banford and David J. Timson
Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?
Journal:
Current Drug Targets
Volume:
18
Page:
13-26
Author(s):
Giulio Rossi, Moira Ragazzi, Ione Tamagnini, Maria C. Mengoli, Giada Vincenzi, Fausto Barbieri, Silvia Piccioli, Alessandra Bisagni, Tiziana Vavala, Luisella Righi, Silvia Novello, Francesco Gelsomino and Marcello Tiseo
LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Journal:
Current Drug Targets
Volume:
18
Page:
27-34
Author(s):
Gerardo Botti, Laura Marra, Maria Gabriella Malzone, Annamaria Anniciello, Chiara Botti, Renato Franco and Monica Cantile
Targeting MET Receptor in Rhabdomyosarcoma: Rationale and Progress
Journal:
Current Drug Targets
Volume:
18
Page:
98-107
Author(s):
Barbara Szewczyk, Klaudia Skrzypek and Marcin Majka
Transcriptional Regulation of mPGES1 in Cancer: An Alternative Approach to Drug Discovery?
Journal:
Current Drug Targets
Volume:
18
Page:
119-131
Author(s):
Meera Ramanan and Mukesh Doble
EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo
Journal:
Current Cancer Drug Targets
Volume:
17
Page:
89-97
Author(s):
Chenfei Zhou, Liangjun Zhu, Jun Ji, Fangmi Ding, Chao Wang, Qu Cai, Yingyan Yu, Zhenggang Zhu and Jun Zhang